Glenmark Life Sciences Limited (GLS.NS)
INR 1030.55
(-0.07%)
INR 1030.55
(-0.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.97 Billion INR | 5.34% |
| 2022 | 6 Billion INR | 3.77% |
| 2021 | 5.78 Billion INR | 3.06% |
| 2020 | 5.61 Billion INR | 26.56% |
| 2019 | 4.43 Billion INR | 88.22% |
| 2018 | 2.35 Billion INR | 1813969.23% |
| 2017 | -130 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.19 Billion INR | -17.8% |
| 2024 Q1 | 1.45 Billion INR | 11.58% |
| 2023 Q4 | 1.3 Billion INR | -19.26% |
| 2023 FY | 6.32 Billion INR | 5.34% |
| 2023 Q3 | 1.61 Billion INR | 1.1% |
| 2023 Q2 | 1.59 Billion INR | -11.76% |
| 2023 Q1 | 1.8 Billion INR | -8.7% |
| 2022 Q3 | 1.41 Billion INR | -1.69% |
| 2022 Q2 | 1.43 Billion INR | 4.99% |
| 2022 Q1 | 1.36 Billion INR | 2.62% |
| 2022 FY | 6 Billion INR | 3.77% |
| 2022 Q4 | 1.97 Billion INR | 39.95% |
| 2021 FY | 5.78 Billion INR | 3.06% |
| 2021 Q1 | 1.55 Billion INR | -3.88% |
| 2021 Q4 | 1.33 Billion INR | -2.15% |
| 2021 Q3 | 1.36 Billion INR | -13.54% |
| 2021 Q2 | 1.57 Billion INR | 1.39% |
| 2020 Q4 | 1.61 Billion INR | 10.19% |
| 2020 Q1 | 1.29 Billion INR | 0.0% |
| 2020 Q3 | 1.46 Billion INR | 23.83% |
| 2020 Q2 | 1.18 Billion INR | -8.46% |
| 2020 FY | 5.61 Billion INR | 26.56% |
| 2019 FY | 4.43 Billion INR | 88.22% |
| 2018 FY | 2.35 Billion INR | 1813969.23% |
| 2017 FY | -130 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -509.215% |
| Ind-Swift Limited | 1.22 Billion INR | -632.419% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -1712.125% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 91.408% |
| Innova Captab Limited | 2.53 Billion INR | -254.431% |
| Divi's Laboratories Limited | 18.31 Billion INR | 50.96% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -100.702% |
| Morepen Laboratories Limited | 4.17 Billion INR | -115.131% |
| Mankind Pharma Limited | 40.86 Billion INR | 78.029% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -425.958% |
| Laurus Labs Limited | 3.94 Billion INR | -127.402% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -130.793% |
| Alembic Limited | 767.77 Million INR | -1069.516% |
| Hikal Limited | 1.49 Billion INR | -500.936% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -55.94% |
| Neuland Laboratories Limited | 5.31 Billion INR | -68.842% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -19.061% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -38.091% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -81.684% |
| Themis Medicare Limited | 1.3 Billion INR | -589.061% |
| RPG Life Sciences Limited | 2.29 Billion INR | -291.711% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 80.219% |
| Lupin Limited | 27.75 Billion INR | 67.652% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -1345.861% |
| Wockhardt Limited | 140 Million INR | -6313.707% |
| Vaishali Pharma Limited | 6.29 Million INR | -142562.695% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -187.048% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -4095.099% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -73.043% |
| FDC Limited | 3.03 Billion INR | -195.978% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 86.742% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -4215.881% |
| Eris Lifesciences Limited | 5.18 Billion INR | -73.286% |
| Venus Remedies Limited | 534.65 Million INR | -1579.449% |
| ZIM Laboratories Limited | 1.09 Billion INR | -717.693% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -629.422% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1527.877% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -24.274% |
| Shilpa Medicare Limited | 3.76 Billion INR | -138.708% |
| Albert David Limited | 1.33 Billion INR | -572.872% |
| Ajanta Pharma Limited | 19.67 Billion INR | 54.368% |
| Hester Biosciences Limited | 364.77 Million INR | -2361.603% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -94.876% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 333.05% |
| Gufic Biosciences Limited | 2.89 Billion INR | -210.29% |
| Windlas Biotech Limited | 1.29 Billion INR | -591.297% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -222.297% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -317093.286% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -32601.544% |
| Granules India Limited | 6.52 Billion INR | -37.543% |
| Aarti Drugs Limited | 7.14 Billion INR | -25.606% |
| Bal Pharma Limited | 214.56 Million INR | -4084.756% |
| Alkem Laboratories Limited | 19.46 Billion INR | 53.863% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 91.391% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -371.02% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -3678.15% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -43370.13% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -280.3% |
| Medico Remedies Limited | 277.11 Million INR | -3140.205% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -346.941% |
| Ipca Laboratories Limited | 29.59 Billion INR | 69.661% |
| Brooks Laboratories Limited | -72.25 Million INR | 12527.601% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -3502.469% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 64.558% |
| NATCO Pharma Limited | 25.96 Billion INR | 65.414% |
| Suven Life Sciences Limited | -1.22 Billion INR | 832.504% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -71.824% |
| Indoco Remedies Limited | 1.52 Billion INR | -489.031% |
| Alpa Laboratories Limited | 61.51 Million INR | -14496.749% |
| Lasa Supergenerics Limited | -458 Million INR | 2060.5% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 318.204% |